The Toulouse Graduate School (Master-PhD) of Cancer Ageing and REjuvenation (CARE) is a unique opportunity to promote one of the world highest quality education and research center in the shared fields of Cancer and Ageing.
CARE is built on the outstanding activity of the TOUCAN LabEx, the WHO’s geriatric reference center (Gerontopole) and cancer hospital of Toulouse (IUCT) and on a strong network of international academic and industrial partnerships. The main goal is to propose disruptive high-level education actions in the area of cancer, ageing, rejuvenation sciences and engineering in Toulouse through an international network. This new educational program, implemented in tight relation with research centers in Toulouse, aim at boosting scientific innovation from fundamental concepts to industrial and medical applications.
Guided by the aim of drastically shortening the time-lag from basic research discoveries to the clinic and socio-economic valorization and push translation of findings into real life through public-private partnerships, CARE promote a unique range of educational tracks from master to PhD involving all the academic, industrial, socio-economic actors.
This EUR, based on the unique « Langlade Campus Biosanté », has a major structuring effect and boost international attractiveness by fostering ambitious and intimately bound research, development and disruptive educational actions.
We are creating an international network of strategic and outstanding partners for the next 10 years: Center on ageing, Mayo clinic (USA); Molecular Biology Center (Madrid); Geriatric center, Milan (Italy); Supercomputing Center (Barcelona)… Furthermore, CARE is supported by key international companies (Roche, Nestlé, P. Fabre, Thales, Alphamos, Ambiotis,…) major research institutes (Univ. of Toulouse, Inserm, CNRS, INSA, Genotoul, EFS), foundations (Toulouse Cancer Santé, La Ligue contre le Cancer 31) and institutional partners (Région Occitanie, Toulouse metropole).
The rationale of such an EUR is based on common concepts developed on both ageing and cancer from a very detailed mechanistic up to an « in-use » therapeutic view. They are proposed all along the master PhD-track through an original education program, widely open to international partners and tightly linked to our entire industrial and academic network, including technological platforms, clinical services and socio-economic actors. In this view, CARE propose a complete transversal program allowing to the professionals and leaders of tomorrow to be in line with the new jobs in the essential fields for the unprecedent mutation of medicine and biomedical sciences. It means that biomedical sciences will be complemented for our student with innovative interdisciplinary courses, including physics, informatics, and mathematics. From the M1, students are in permanent immersion in academic or industrial research laboratories to facilitate training through research.
Moreover, the strong interplay between universities involved in CARE favors both incoming and outcoming student fluxes and the settlement of future competitive networks. Thus, dedicated mobility scholarship is offered to outstanding foreign and domestic students in order to improve communication skills and develop new performances. Our ambition for the CARE PhD track is to dramatically modify the “classical” vertical way of teaching by focusing on the ability (i) to bring positive criticism (by sorting valuable information from the huge amount available), (ii) to stimulate creativity (by a large transdisciplinary formation), (iii) to promote collaboration (by international academic and non-academic interactions) and (iv) to improve communication skills (by using up to date supports). This definitely encourage students to become proactive in their own education and career perspectives, facilitating their professional insertion.
